Once-Daily Tacrolimus In Patients Undergoing Kidney Transplantation And Steroid Withdrawal
Posted Date: May 24, 2019
- Investigator: Simon Tremblay
- Specialties: Kidney Disease, Nephrology, Transplant Nephrology
- Type of Study: Drug
This study is designed to evaluate the safety and efficacy of once-daily tacrolimus in combination with induction medicine (rabbit antithymocyte globulin), in combination with standard immunosuppression regimens (mycophenolate and steroid withdrawal).
Adults Receiving A Living Or Deceased Donor (Certain Exceptions Apply) Kidney Transplant May Be Eligible To Participate.
Envarsus, Kidney Transplant, Steroid Withdrawal
For More Information: